Nutraplus India Ltd

Nutraplus India Ltd has submitted revised Standalone Financial Results for the year ended March 31, 2025, following a query from BSE. The company's Board of Directors approved the unaudited standalone financial results with a limited review report for the quarter ended March 31, 2025, during a meeting held on July 15, 2025. The filing includes detailed financial statements for the quarter and year, showing a net loss for the period. The auditors have issued a qualified opinion, noting that the results are not presented in accordance with certain listing regulations, though they do provide a true and fair view otherwise.

Nutraplus India Ltd has submitted revised standalone financial results for the quarter and half-year ended September 30, 2025, following a query from BSE. The company's Board of Directors approved these unaudited results with a limited review report on October 25, 2025. The auditor's report highlights a qualified opinion due to the company's non-compliance with listing requirements regarding timely submission of financial reports and provision of necessary data. Additionally, a significant emphasis of matter points to the loss of all property, plant, and equipment under the SARFEASI Act, 2002, due to the company being declared an NPA in FY 2019-20, with auction delays attributed to the COVID-19 pandemic.

Nutraplus India Ltd. announces plans to establish a Commercial Bio Gas (CBG) plant, leveraging government initiatives like the GOBAR-DHAN scheme. The company has identified vendors and land for the project, aiming to address the energy crisis and promote self-sufficiency. The project aligns with a zero-waste circular economy, focusing on renewable energy and exploring carbon credits. The initiative supports the government's push for biogas blending and organic fertilizer production, potentially cutting imports and chemical fertilizer use.

Nutraplus India Ltd declares audited standalone financial results for the quarter and year ended March 31, 2026. The company's financials reveal a total income of ₹6.10 Lacs for the quarter ended March 31, 2026, and ₹15.77 Lacs for the year ended March 31, 2026. The company reported a net profit after tax of ₹4.46 Lacs for the quarter and a loss of ₹34.01 Lacs for the year. The company lost all its property, plants & equipments under SARFESIA ACT, 2002 and Going Concern concept is completely vitiated.

Nutraplus India Ltd's board met on May 25, 2026, and approved the audited standalone financial results for the quarter and year ended March 31, 2026. The company reported a net profit after tax of ₹4.46 Lacs for the year ended March 31, 2026, compared to a net loss of ₹5.01 Lacs in the previous year. The company's operations fall under the Active Pharmaceutical Ingredient (API) segment. The company lost all its property, plants & equipments under SARFESIA ACT, 2002.

Nutraplus India Ltd has scheduled a Board of Directors meeting on May 25, 2026, to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities has been closed since April 1, 2026, and will remain closed until 48 hours after the announcement of the financial results.

Nutraplus India Ltd. announced the closure of its trading window for designated persons from January 1, 2022, until 48 hours after the announcement of the unaudited financial results for the quarter and nine months ended December 31, 2021. The date of the board meeting to consider and approve the results will be communicated separately.

Nutraplus India Ltd's Board of Directors, at its meeting on October 14, 2024, approved the unaudited financial results for the quarter ended December 31, 2021. The company also submitted a Limited Review Report from Raman S. Shah & Associates, which was a Qualified Limited Review Report. The review was conducted in accordance with the Standard on Review Engagements (SRE) 2410.

Nutraplus India Ltd's Board of Directors, at a meeting held on September 21, 2024, approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2020. The company submitted these results along with a Limited Review Report from Raman S. Shah & Associates, Chartered Accountants. The auditor's report is a Qualified Limited Review Report, indicating certain matters described in paragraph 4 (Basis for Qualified Limited Review Report) that prevent a clean opinion on the financial statements.

Nutraplus India Ltd's Board of Directors approved the audited standalone financial results with the Limited Review Report for the quarter ended June 30, 2021, in a meeting held on October 4, 2024. The meeting commenced at 11:30 a.m. and concluded at 1:00 p.m. The approved financial results and reports have been enclosed with the filing.